NCT06535490View on ClinicalTrials.gov

Antibiotic Prophylaxis for EUS-FNA of Pancreatic Cystic Lesions

Not yet recruitingOBSERVATIONAL

Enrollment

1,702

Participants

Timeline

Start Date

September 15, 2024

Primary Completion Date

September 15, 2027

Study Completion Date

October 15, 2027

Conditions

Pancreatic Cystic Lesion

Interventions

PROCEDURE

EUS-FNA

Puncture of pancreatic cystic lesion with a fine needle under EUS guidance

DRUG

ATBp

Antibiotic prophylaxis consists of a single intravenous administration before or at the beginning of the procedure according to the common practices of each practitioner or unit

Trial Locations (1)

94220

Clinique Paris-Bercy, Charenton-le-Pont

All Listed Sponsors

lead

Société Française d'Endoscopie Digestive

OTHER

NCT06535490 - Antibiotic Prophylaxis for EUS-FNA of Pancreatic Cystic Lesions | Biotech Hunter | Biotech Hunter